1. Cablivi (caplacizumab) is a medication used to treat adults with acquired thrombotic thrombocytopenic purpura (aTTP), a rare blood disorder that can lead to heart failure if left untreated.
2. Cablivi works by inhibiting the formation of blood clots, which can help prevent further damage to the heart and other organs.
3. It is administered through an intravenous infusion and is typically given in combination with other medications to manage aTTP.
4. Cablivi has been shown to significantly reduce the time to platelet count response in patients with aTTP, which can help improve outcomes and reduce the risk of heart failure.
5. Common side effects of Cablivi may include headache, bleeding, and allergic reactions. It is important to talk to your healthcare provider about any potential risks before starting treatment.
6. Cablivi is not recommended for use in pregnant women, as it may cause harm to the developing fetus. It is important to use effective birth control while taking this medication.
7. It is important to follow your healthcare provider's instructions carefully when taking Cablivi, as missing doses or stopping treatment prematurely can increase the risk of complications.
8. Cablivi may interact with other medications, so it is important to inform your healthcare provider about all the medications you are taking before starting treatment.
9. If you experience any new or worsening symptoms while taking Cablivi, such as chest pain, shortness of breath, or swelling in the legs, it is important to seek medical attention immediately.
10. Cablivi can be a life-saving medication for individuals with aTTP, but it is important to work closely with your healthcare provider to monitor your condition and adjust your treatment plan as needed.